Oncolytic parvoviruses as cancer therapeutics

The experimental infectivity and excellent tolerance of some rodent autonomous parvoviruses in humans, together with their oncosuppressive effects in preclinical models, speak for the inclusion of these agents in the arsenal of oncolytic viruses under consideration for cancer therapy. In particular,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Rommelaere, Jean (VerfasserIn) , Geletneky, Karsten (VerfasserIn) , Angelova, Assia L. (VerfasserIn) , Daeffler, Laurent (VerfasserIn) , Dinsart, Christiane (VerfasserIn) , Kiprianova, Irina (VerfasserIn) , Schlehofer, Jörg R. (VerfasserIn) , Raykov, Zahari Zahariev (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 7 March 2010
In: Cytokine & growth factor reviews
Year: 2010, Jahrgang: 21, Heft: 2/3, Pages: 185-195
ISSN:1879-0305
DOI:10.1016/j.cytogfr.2010.02.011
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.cytogfr.2010.02.011
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S1359610110000225
Volltext
Verfasserangaben:Jean Rommelaere, Karsten Geletneky, Assia L. Angelova, Laurent Daeffler, Christiane Dinsart, Irina Kiprianova, Joerg R. Schlehofer, Zahari Raykov

MARC

LEADER 00000caa a2200000 c 4500
001 1849817405
003 DE-627
005 20230710130622.0
007 cr uuu---uuuuu
008 230615s2010 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.cytogfr.2010.02.011  |2 doi 
035 |a (DE-627)1849817405 
035 |a (DE-599)KXP1849817405 
035 |a (OCoLC)1389794119 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Rommelaere, Jean  |d 1948-  |e VerfasserIn  |0 (DE-588)1201673909  |0 (DE-627)1685754767  |4 aut 
245 1 0 |a Oncolytic parvoviruses as cancer therapeutics  |c Jean Rommelaere, Karsten Geletneky, Assia L. Angelova, Laurent Daeffler, Christiane Dinsart, Irina Kiprianova, Joerg R. Schlehofer, Zahari Raykov 
264 1 |c 7 March 2010 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 15.06.2023 
520 |a The experimental infectivity and excellent tolerance of some rodent autonomous parvoviruses in humans, together with their oncosuppressive effects in preclinical models, speak for the inclusion of these agents in the arsenal of oncolytic viruses under consideration for cancer therapy. In particular, wild-type parvovirus H-1PV can achieve a complete cure of various tumors in animal models and kill tumor cells that resist conventional anticancer treatments. There is growing evidence that H-1PV oncosuppression involves an immune component in addition to the direct viral oncolytic effect. This article summarizes the recent assessment of H-1PV antineoplastic activity in glioma, pancreatic ductal adenocarcinoma, and non-Hodgkin lymphoma models, laying the foundation for the present launch of a first phase I/IIa clinical trial on glioma patients. 
650 4 |a Cancer immunotherapy 
650 4 |a Cancer virotherapy 
650 4 |a Clinical trial 
650 4 |a Immunomodulation 
650 4 |a Oncolysis 
650 4 |a Oncosuppression 
650 4 |a Parvoviruses 
700 1 |a Geletneky, Karsten  |d 1964-  |e VerfasserIn  |0 (DE-588)123632862  |0 (DE-627)706375475  |0 (DE-576)293799326  |4 aut 
700 1 |a Angelova, Assia L.  |e VerfasserIn  |4 aut 
700 1 |a Daeffler, Laurent  |e VerfasserIn  |0 (DE-588)1227507909  |0 (DE-627)174851234X  |4 aut 
700 1 |a Dinsart, Christiane  |e VerfasserIn  |0 (DE-588)1226990649  |0 (DE-627)1748090747  |4 aut 
700 1 |a Kiprianova, Irina  |d 1961-  |e VerfasserIn  |0 (DE-588)121272877  |0 (DE-627)705350215  |0 (DE-576)292620772  |4 aut 
700 1 |a Schlehofer, Jörg R.  |e VerfasserIn  |0 (DE-588)1077762925  |0 (DE-627)837468833  |0 (DE-576)446652741  |4 aut 
700 1 |a Raykov, Zahari Zahariev  |d 1971-  |e VerfasserIn  |0 (DE-588)124597963  |0 (DE-627)36343478X  |0 (DE-576)294251359  |4 aut 
773 0 8 |i Enthalten in  |t Cytokine & growth factor reviews  |d Amsterdam [u.a.] : Elsevier Science, 1996  |g 21(2010), 2/3 vom: Apr./Juni, Seite 185-195  |h Online-Ressource  |w (DE-627)320651045  |w (DE-600)2025966-9  |w (DE-576)103939245  |x 1879-0305  |7 nnas  |a Oncolytic parvoviruses as cancer therapeutics 
773 1 8 |g volume:21  |g year:2010  |g number:2/3  |g month:04/06  |g pages:185-195  |g extent:11  |a Oncolytic parvoviruses as cancer therapeutics 
856 4 0 |u https://doi.org/10.1016/j.cytogfr.2010.02.011  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S1359610110000225  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230615 
993 |a Article 
994 |a 2010 
998 |g 124597963  |a Raykov, Zahari Zahariev  |m 124597963:Raykov, Zahari Zahariev  |d 50000  |e 50000PR124597963  |k 0/50000/  |p 8  |y j 
998 |g 1077762925  |a Schlehofer, Jörg R.  |m 1077762925:Schlehofer, Jörg R.  |d 50000  |e 50000PS1077762925  |k 0/50000/  |p 7 
998 |g 121272877  |a Kiprianova, Irina  |m 121272877:Kiprianova, Irina  |d 910000  |d 911100  |e 910000PK121272877  |e 911100PK121272877  |k 0/910000/  |k 1/910000/911100/  |p 6 
998 |g 1226990649  |a Dinsart, Christiane  |m 1226990649:Dinsart, Christiane  |d 50000  |e 50000PD1226990649  |k 0/50000/  |p 5 
998 |g 1227507909  |a Daeffler, Laurent  |m 1227507909:Daeffler, Laurent  |d 50000  |e 50000PD1227507909  |k 0/50000/  |p 4 
998 |g 123632862  |a Geletneky, Karsten  |m 123632862:Geletneky, Karsten  |d 50000  |e 50000PG123632862  |k 0/50000/  |p 2 
998 |g 1201673909  |a Rommelaere, Jean  |m 1201673909:Rommelaere, Jean  |d 50000  |e 50000PR1201673909  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1849817405  |e 4338797150 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 15.06.2023"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1849817405","language":["eng"],"person":[{"given":"Jean","family":"Rommelaere","role":"aut","display":"Rommelaere, Jean","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Geletneky, Karsten","roleDisplay":"VerfasserIn","given":"Karsten","family":"Geletneky"},{"family":"Angelova","given":"Assia L.","display":"Angelova, Assia L.","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","display":"Daeffler, Laurent","roleDisplay":"VerfasserIn","given":"Laurent","family":"Daeffler"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Dinsart, Christiane","given":"Christiane","family":"Dinsart"},{"family":"Kiprianova","given":"Irina","display":"Kiprianova, Irina","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Schlehofer","given":"Jörg R.","display":"Schlehofer, Jörg R.","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","display":"Raykov, Zahari Zahariev","roleDisplay":"VerfasserIn","given":"Zahari Zahariev","family":"Raykov"}],"title":[{"title_sort":"Oncolytic parvoviruses as cancer therapeutics","title":"Oncolytic parvoviruses as cancer therapeutics"}],"physDesc":[{"extent":"11 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["320651045"],"zdb":["2025966-9"],"issn":["1879-0305"]},"origin":[{"publisherPlace":"Amsterdam [u.a.]","publisher":"Elsevier Science","dateIssuedDisp":"[1996]-"}],"titleAlt":[{"title":"Cytokine and growth factor reviews"}],"part":{"year":"2010","issue":"2/3","pages":"185-195","text":"21(2010), 2/3 vom: Apr./Juni, Seite 185-195","volume":"21","extent":"11"},"pubHistory":["Vol. 7, no. 1 (1996)-"],"recId":"320651045","language":["eng"],"disp":"Oncolytic parvoviruses as cancer therapeuticsCytokine & growth factor reviews","note":["Gesehen am 03.04.2023","Ungezählte Beil.: Supplement"],"type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"title_sort":"Cytokine & growth factor reviews","title":"Cytokine & growth factor reviews"}]}],"name":{"displayForm":["Jean Rommelaere, Karsten Geletneky, Assia L. Angelova, Laurent Daeffler, Christiane Dinsart, Irina Kiprianova, Joerg R. Schlehofer, Zahari Raykov"]},"origin":[{"dateIssuedDisp":"7 March 2010","dateIssuedKey":"2010"}],"id":{"eki":["1849817405"],"doi":["10.1016/j.cytogfr.2010.02.011"]}} 
SRT |a ROMMELAEREONCOLYTICP7201